Corporate News     11-Dec-20
Alembic Pharmaceuticals receives USFDA approval for Asenapine Sublingual Tablets
Alembic Pharmaceuticals announced it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Asenapine Sublingual Tablets, 5 mg and 10 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Saphris Sublingual Tablets, 5 mg and 10 mg, of Allergan Sales, LLC (Allergan). Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults.

Alembic had previously received tentative approval for this ANDA. Alembic was one of the first ANDA applicants to submit a substantially complete ANDA with a paragraph IV certification and hence is eligible for 180 days of shared exclusivity.

Asenapine Sublingual Tablets, 5 mg and 10 mg have an estimated market size of US$ 217 million for twelve months ending September 2020 according to IQVIA.

Previous News
  Alembic Pharmaceuticals to convene board meeting
 ( Corporate News - 18-Jan-23   10:51 )
  Alembic Pharma gets PAS nod from USFDA for pregabalin capsules
 ( Hot Pursuit - 22-Dec-22   14:57 )
  Alembic Pharmaceuticals receives USFDA approval for various products
 ( Corporate News - 09-May-24   09:01 )
  Alembic Pharma buys out Orbicular's stake in Aleor Dermaceuticals
 ( Hot Pursuit - 29-Mar-22   15:23 )
  Alembic Pharma Q3 PAT slips 29% YoY; R&D spend at Rs 157 crore
 ( Hot Pursuit - 02-Feb-23   10:41 )
  Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide Ointment
 ( Corporate News - 08-Mar-22   15:01 )
  Alembic Pharmaceuticals to acquire 40% stake in Aleor Dermaceuticals
 ( Corporate News - 29-Mar-22   15:41 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 30-Nov-23   14:30 )
  CRISIL reaffirms ratings of Alembic Pharmaceuticals with 'stable' outlook
 ( Hot Pursuit - 08-Mar-24   11:22 )
  Aleor Dermaceuticals receives USFDA tentative approval for Efinaconazole Topical Solution
 ( Corporate News - 08-Apr-21   11:44 )
  Alembic receives final approval for Fluorouracil Injection
 ( Corporate News - 06-Mar-23   11:32 )
Other Stories
  Tridhya Tech to convene board meeting
  03-Jul-24   20:06
  Sonu Infratech schedules EGM
  03-Jul-24   19:59
  Sakuma Exports to convene AGM
  03-Jul-24   19:59
  Time Technoplast repays commercial paper
  03-Jul-24   18:31
  Board of Aditya Vision approves stock split and listing of share on NSE
  03-Jul-24   18:24
  Pricol director resigns
  03-Jul-24   18:21
  Board of VMS Industries recommends first interim dividend
  03-Jul-24   17:49
  Lakshmi Machine Works to declare Quarterly Result
  03-Jul-24   17:44
  Modison to convene AGM
  03-Jul-24   17:43
  Sybly Industries to discuss results
  03-Jul-24   17:43
Back Top